After HBsAg loss in a noncirrhotic patient with prior long-term nucleos(t)ide therapy and a first-degree family history of HCC, do you ever stop HCC surveillance?
If so what risk tool or threshold (age at seroclearance, fibrosis markers, metabolic risk) determines discontinuation vs lifelong ultrasound±AFP?